The neuroexcitant effects of aspartame: an investigation using kindling by Rolfe, Paula C.




-',
\
The Neuroexcitan.t ECCe'c'ts orAsparta.me: !
A.l1 Investiga tion Using Kindling .
BY
© Paula C. RoICe, B.Sc.(Hons.)
. ~ . ~
A - ~ b~is ~~~m~tted -,tothe School or Grad uate / /
Studies in par t ial fulfillment -ot th e
rcqulr cments tor th e d~ee of
'MJISters or Science
11 Department of P sycbology
Memorial Universit~ orNewfoundland
February, 1990
St. Job~'s Newfoundland
The -a ut h o r · ( copyright owner) L' .auteur (titulaire dp. droit
, b 'a. ·r e s e r v e d " o t h e r d 'auteur) se ' r &Be r v e le.s
\ publica ,tion rights, a n d autres droitB de pU1;)lieationf
ne i the~/ th e thesis ,no r I n i la ,th ~ l!l e ni _ ~e ' longs
:=~~~~iVp~i:::~a~:8~t~~;w'i~;: -, ~~i:::t~'!1 et~ee :~e;p;i;, l ' ~~
reproduced without his/her -, .a~t.rell.ent reproduits san~ ·80n. '
wri tt ,n ~,rmis8ion. . ( -_.- outorisotlon ~crite. ,
,
Perlldssion ha s. be en grante.d
t o ' the National Library ' of
Canada t o .i...~rofilm this
thesi s and t o lend or: sel,1-
c;:opi es of the fllm. ~
L'aut.oriaat ion a -', t ' accordee
, A. . la . Biblioth~quenationale . ~ ~ .
du . Canada d e .icrof~l.er
c eeee these et de preter a u
de vendre ' des eJ:elllplairee du
fUm.
I,
-;
, ~DsumptioD .
.:
' , - -
" " .
A great deal of cont roye n ial evidence bas arisen rer;ardiog tbe arti ficial
. sweetener Aspartame iNutraSweet~\Thi5 dipept ide is eomposed of ' ';'0 aminO"
a~ids tb~t bave' ~D SbOWD to bave detr~eDtt.i erred. on , bnin/ behAvior
fuuction (OlDey aDd' Ho, 1070; Nyhan, 1084; Wurtm.~', _l083B).• AsPar~ e .
~ ingestion causes a sigDificanf Ieereeee in braiD ph enylalanin e an d tyrOsIne, &Dd a
d~rease in brain tryp tophan (Wortman, 1983), ~bieh may change ' btai~ . :-&
. excit ab ility (Racine and eos'dD~, 1070i Cade.tf. lI ar low,-IlOd Waism.aD, 1962). 'The . "
purpose of the present study was to determin e-if asp: rb.m e coDsump~ioD rO~ a one .;'
week period changed brain excitabili ty by reduci ng arter.d ischa rge .tbr,esholds as ... :i': ~
measured by the kindlini,tf,chniq ue,'An imals ~ere Bte r~tacti;a~IYlrh.~lanted · ~.ith . ~
0", bipol... ~Ie"'~d~ lo' AmCA' 01 lh ; I!jPPOO';"pu.: A(i.e~d;';h..g"" ~... .. '~'.,~.~._:.•';~
obtained for aU animals ' (Day 0). , .Th e 'groups ,were: G' 9up 0, animab tha.t ". . : _ ~~
consumed water , Group .200, &nimala than:oosumed 2~g/k-s' of '~~art~e in ' ' . \~~. ."')
w~te;, ~nd Group 800, animals ~h.t ooD!lumed.~gik~ or ~pa~iime . in ~~ier. \. :,;l;r~':;!:\~':~:u:'~::~:~h~d;a~:I~;~: ;hf~~:~r ::~:::::;...'..\.~aspa~tame roDa~niptio Q . · AII '~imals were ·.timui~ied t~o'or "'three ~~-es a day . . ~,j
with ;h~ inter-stimul.. ;o"," aI'beio~ ~l le"'l 10", hou... Th ie w;" eo'lloued o~iil : jJ
tbr~ 'Stage-S ae ilur~ .wer. -obtained.. - A geDeraliled - aei~ure t~i~~g-\hrelbold . ,:/;.
(6 ST) was then obtai~ed . The ;esults show thai there 'were DO significant .' i~
dirferences betw een rood toDSumpUo~, li~uid co nsumptio n" weight gain ;;rdtei. . .'~
disch~rge threshold~ be;~eeD the .grou~s., ... Mter-~is~ge ~ thr esholds, . were i/' .t
s.i~ific~ntly difrerent over .day•. A New~an-Kuel! analy.is comparing arter- ,' .',.'
discharg e thresholdsefor days showed Dare> > Day I > Day 1 ,'~nd 'the ADT for .' ' -':'
, Day 1 > GST . This· w~ ee e~peded finding sin~e af~~r-d~eharge<thresholds del · . :~j
'decrease with rep~ated sti~U lati~D~ (Racine , 1972~. , Ho;e~er l brai n e~citabiiii~ . .,
is not altere d .b~ ,aspartame consu~p~iO~ U~ing . tbe p~edure employed ~/this ' :~;
~s t.~dY , n~r was the.re any d ~.rrerence roun~_iD br~ ~i~o-ac:~d. levels. luture....- . :.~_.'•.
etudiee ehould include a more ' detailed analy.is on '. .long-term as~rtame
I . / ' . . ~
'I" :' o ;{j
. /: ····;te
.(~,;.~.•..,-.'...:;. ..:~:.~.:;L ;;;;·.:·;;:·{ir'
.;:.;::_:. ;,-.10'_>.' , ' ~ ~
Kef Wordst Aspartame (APM), Kindlin-~,~psy, Phenylalanine (PIlE) ,
Aspertlc . Acid (ASP), TYr08.ine (lfYR), T ryptophan .(TRP),
Serotonin (&-HT), Al~r-dis~ha~'ge Thr eshold (ADT ), After·d ischfLrge
(AD), Generalizes! Triggering Seizure Thr eshold (GST), Glutamate
(GLU), Seizure.
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, ,Low rakui e ....tificial aweetenin( agents app~ar to serve a useful soda] fUDelion,
Th e availabUd, of acceptable sweeteners has ' impor~'ant therapeutic' ~d
psychological implications, A reduction in the intake of aimple sugars is a4~oca~
for the prevention o( dental eaYities; prevention and i reatment of' obesity, and
t:eatment of dla~tes . Art ificial swee~en ing -agents pro~ide a decrease_inciav,ities,
a decrease.in carbohydra tes for obese 'persons and . fJecreu e .in sugar. levels in tbe ·
-. blood for persons w.bo_are' diabeti1!: , -
•
• ' One of the most common arWieial sweetening agents on the ,m~rk.et .today is
A!lpar~ame (NutraSw,e.~t.l .'· Aalarta~~ (APM) ' is· .a dipeptid~ ,~lrJlS~arty~L:.
: ' pben! lalanyl- methyl .e:'J t~ r ) with a sweetening ~wer of ISOtoJOO ti~es th";.t <of :
eueroee in aqueous solution (Steg!nk,Filer,and lraker, 1m) (see Figure II, In the
) . i n tesUD~ m~~a, AP'1 is h~dro~zet i~to th; t~d'.,mi~.? acids~.O%~parti~ ~id :
"". . (ASP), 50% pben;l alanine jPIIE), and 'met~anol (Rai:J.Dey, Op~rmann .. Muldoon •
\ . an~ ~cMa~~n: lvi-6): ~ . '.!'he iwo amino acids'~; rileiaboliZed;m"ti1ar.,._, _to . ~he_ "
amino acids ariSingJrom Clid ary prote in. Th e Iweet fin or in humans is a resulLof ' ,
the aspartat~' mblenJe interacting ~ith taste receptors 00 the ton~e (I~~murl,
1~), However. in ;~ts -there is lit tle evidence that APM is sweet',~r palat i ble
. ~ . . .
..J like 8UC~) since DO difference was found wbe~ APM or water C?nsumptioD was
. measured (Sclafani ~nd Abr ams, 1086).
Questions r~gardiD~' the salety , of aspartam e have arisen ' bec~u.!le of conc!!rn
, -,' . ' . " .. ' ....
abou t the potential harmful effects of elevated level! of the amino acids, ASP and
, PHE, .aIl.~ the 'metabolite methano l and its ~r-pro(uet dike,k.pipe;az ine:
T he' intrdduction will be' \ 8\l~divide~ i4to -the possible 8u~sections t~a( ¥ e' .
arfeded'or altered by the consumpt ion or 'APM or )h~ amino acidS th at comPose
..\pM.' · ..... .,
" :~'.' .
:'. ~:
. - , : ~
.'
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,
A' chemical configurati on oC th e-eeper teme molecule, showing
th'e position or t he is partic 'acid (ASP) and th e methyl ester
(MEOH) or pben ylalanin e (PHE),
. qne , impo rtant source or' po tential ,barm ill th at inges~on of APM rna.·y alte.r
bra in levels of amino acids. The brain req uires' amino acids for the synthesis of
peptides; : proteins, ~nd ,neurotr&D8mitt~ such IL'I serotonin, dopamine, and
nor~pin~pbrine. Amino acids that are not synthesized within the brain must be
ta ken fro m the blood across the blood~brain barrier (BBB). In mammals the BBB
is located at the endothelial cells of cerebra l capillaries. Th e endot helial cells are
jo ined by tight junct ions and substrates must pess thrcugb ., two - capi1l ~ry
membranes in o~der to reach I).ra in extrace llular fluid. Hence, tr ansport thr ough
the BBB depends on lipid - solubility or mediation 0'" specific carriers in the
capilla.ry cell memb~anes . (Pardrid~e, 11)83·). The tr ansport ' m~chanism is -
dependent upon -the characte rist ics 01 the part icular amino acid to be transpo rted.
T here are three di~ti~ct carrjera; one fOT n eutral' amino ac ids, one 'br b8.9i~ ' amino
acids, and one for dlceeboxylic am ino acids. Most of -t he amino acids enter the
brai~ rr~m biood by syst~JD9 which sho~ aterooi~edficity, ' competitive-inhib~tion
and saturatio n, that ~ollow Miebeelie-Mentcneeturenon kinetics (Pardridge and
.Ol deedorr, UI75). Neut ra l ami no acid uptake into the , brain . is via a single
facilitat ed system end is unique'ly sensitive to ~ompetitive inhibition. Competition
,", 'b~tweeD many neutral amino acids Cor a common)arrier ays£em',ls an important
aspect of ~he regulation of ,the amine acids thlit a~e .!!vailable. in tbe br ain, All
lar ge neu tral amino acids are assume d to' compete for the aame adive" carrier-
mediated transpo rt system located at the BBB (Fer ilstrom, 1981). T hus, if large
imbalances in ~he plasma conce~tj.ation or one or 'severa l neut ra l amino acids
occur lar ge.cha nges in t ranspo rt across t he BBB a':l-d br a in c~ncentr~tions or 'all
competing amino acids change. For e;tanfple, in ' ~the disease P henylketonuria
(PKU). P HE eennot be-converted to tyr~ine (TYR ) (a la rge....neu tr al ~min-o.aeld )
in th,e liver, leaving,an exeessive.eonc~ntr~tion?f PIlE JD the ,bloo d 8~l!PIY .:'YJln "
. th is large neutral amino acid reaches the ~BB its concentration in the blooTis
greater.and thmtore it has more molecules anil.ble to compete tor curier l ites,
henee causing an elented PRE brain lent The metabolites tht aceumulate in
PKU . iDdividuals (phe~J~adie acid and phenyl.e etie acid). inhibit s-
hydroXJ'tryptophan dK'arboIJ lase (Nyban, J084) eausillg .. decrease in &-JIT.
Heaee, in PKU children t he In t is of other :m ino acid. (~~t includin g PHE) and
neu rotran smitters are"decreased (Hcutber, Schott , Sprotte, Th oemke and Neuhoff,
19st). Th e 'concentration in the br ain or&bmeamino acid" arJ 4!"ectll dependent
on plasma roDteDtr~tionll while ot hers are Dol Fernstrom and Wurtman (1V12)
showed that brain TYR ~ ptake and brain s-HT levels were directly propor t ional
to the ratio of the plu ma concent ra tion or TYR to the sum of the large neutr al
. ami no' acids tbat compete with TYR tor t ransport across the BBB . wurtmen,
Larin , Most afapour and , Fernstrom (IU74) have also shown, that brain
ee teeholemlne formation is directly dependent on brain TYR concentratio n . The \...
eoneentrefion of TYR in brain is itself directly,proportional to tb'e rat io 6CTYR )
to large neut ral smi no acids in plasm a. The dependence of .PRE and TYR levels
. in b~ain on their levels.in blood has 'been shown many times-.It was ~onfused hy
P enr , Gubin , Harper, Vavich and' Kemmerer 11073) who sho wed that .with a high
PIlE diet 'the levels of leueiee, isoleucine, ~ethionine and histidine in brain tell
~bil~ in blood they di~ not !h&o ~e. . 'fhis wa.s in alP'eement ·wi·th ·Kennett, .
Cunon, Huat ead Pata.!(I U86).who have show~ tha~ the~o acid levels in the
blood and the amino acid lel-els in the brain appear to .be partl y independ ent.
The,. showed that ' 80me ernlec ecid levels· in the blood ean decrease while 'tbe
amino acid leto,ls in the br aill rema in stabJe or even Iaereeee. Th is d emomlt ra tes
th at some a.minO'-atids may Yery well be "independent in th eir concentra tio ns in
blood versu s. brain , whereas othe rs are not. 'Al though the relatKlDsb ip ot
plasm:J./brain eoncentratioua are not simple, the Iite;ature e n amino acids sbow a
consistent el~vation in, brain if plasma PIlE is elevated. PilE bas a ·powerful
effect.
In a non-PK U individual, consumption of diet ary PRE in th~ usual. way,
through" pr ottin ingestion ,··dO<."ll not elev~te plasma or brain levels of PHE any
.'.>..
. Set'Otonln Mod~latloD Errede.
' . ?.. ... . ".. .
. . ,
.:_, :," , :.~ "'~ .
An exhaus tin inv:,tigatio n of APM's eUed s 0 0 brain amino acids - and
eeurot reasmitter lunctions i! warranted.
. . . . ~
Brain neurotr ansmitt ers.. cha nge as a result 01 rood,COn8 l1mp.ti~n ; Tw o exam ples' •
of th ese are catechola~ines and seroto nin. Th e rates at which ~he rate-limiti~Il:;_ ' )
enzymes tyr osine hydroxylase and ~ryptop.han hyd~oxyltlSe convert TYR to l-dcpe
and t.ryptophan (TRP) to serotc nla , ~espectlveiYJ can simila rly be- modul ated by
trea(n:eols th at chaoge brain levels of TYIt' aod·TRP> lo'gesUon o~-eitber pure
TYR.APMor carbobydrat~ c~ increase bra in TYRlevels {Wl.l.rtman, J~~---J' J
. \
,
1 \ "
more '"'ihan' other amino acids (Yokogosh~ ' Roberti ,"C~bal1ero. and Wartman,
10s4). Amino acids are 'abundan* in tbe .p1asma: llIId only th~ fraDCbed-eb~; .
... amino acids, unlike PIlE , are ~g~IY uD':'le:tabOIiJed whent~~t through the .
portal cireula tioo. . However, w~eD PIlE is eoneumed in the form or ~M .
(34mgj kz or body ~eigbll pluma p~ rises threefold above the Do~mal rise in
". ,the other luge eeut rel amlno acids (S'telink , Filer, Baker, and MeDoooeU, 19~~ ' ' ..
This elevat ioD' ill pluma PHE eauses .. pro portion.! ' rise> in brain PIlE and
decre ase in th e othe; large neutral amiDo •.ddt in bum. 'M~er' an"a Wurtmaa
(l087) stated tbat APM is proba.blY th e ooly PuE- eont aining food that ; levates
tbc{ra !io or~~e concentration of PRE to the summed concentration, or the otb er
large neutra l amino acids.
Brain amino acid imbalances caused by competition at th e BBB are important
when studying tbe patb ogen<;li!J of .genetic ~YPll\phenYlalaninemia or r!'U lCb oi .
and Pardridge, 1086). Th~!,.roble~ (hyperph enylalaninemia or PKU) gain-ev.en
more ~ ign ificll.D ce .with the glob al use or ArM. The . postpr~ndial
- - h~ph~oYlatao i~ernia that is lS5O<:.la ted with APMinll:es~ionea~s~~ .. -aeleet ivt
/ : ~atu~ ~f tb~_ .~!!!!_~_~no._acid · transpor t..,J)'ltem at th e- BBB with PHE
(Pardridr;e; ' lg~II). .'
.,
. -. " -~- ."..'
. t
.....: .
"
·Th••ynth,,~ of ..ro~~;. i:;'HTt.gin;': ..uro.. by tb; bYd~XYI.t;on 01tbe , . .
es5f'ot ia l amino add TRP. Subs t.... es that can raise or lower the leVel o r TRP in
brain ca n r&pid l,. ~baDg~ the.rale .. which TRP is h~droXJlated and conve rted to
ft.IIT. Despite th e fact that tryptoph an hydroxylase ill the ute- limiting step rot 5--
irrSYDt hesis, 5-lq eh aDges upon TRP . ..aUab ility_ O oe exam ple of t his. is the
consum ption o r -. hi(b-car bohydrate, protein-poor mut. Tbi! me al eleYBl es brain
TRP leve~ ~d &cceleratel 5-lIT synt hesis (F eru (rom and WJ!~". 1071).
When 3 g/k'" of glucose and 2OOmgl!¥ or Ar M was intubated into rats, th e ArM.
carbohydrate eombination doubleitt.e PIlE conce ntration In bram, leereesed the
1YR leve,"~\lIuppressed I>y ba it the pbyaiologieal inerellie in brain TRP tba"
would normally aceomp~DY a carbohyd rate-rich meel.. APM ' also ~blocked' th e
normal increase io brain M IT and 5-hyd roxyindo leacetic ac:i!l .llaat isprod uced by
a carbo hydrat e meal (Wurtman, 19888 ). ' . Wurtman '~ugge9 ted th at the
carbohydrates alonelcauk d,an insulin-mediated decre~e in plasml'concentratio~s
of the amino acids that compete .witb.~~~d TYR'f9~ ~ranaPort across t he BB~
(Wurtman , 1088B).' tr t his decrease in the levels of the other pla.'9ma large neutral
amino acids QCcurs',uptake of ' TRP 'in~"'lhe brain ill facilitated and brain s-irr is
,.-'-~-~----:-';' ele~P;TYR,-PHE aDd'otht r lar ge neut raJ amlno.eids ~m)ete .witho~e .
another ' ror tr ansport .:cross the .blood.b rain b'arrler_ -Hcwevee, -it' APM is the-'
main car~hydrate spbst;tute ' tben 'two things a'hould M expected to happen;
. breln TRP aho~ld d~reue. 'and 'circulAting TYR ~nd PHE abo uld be ele",~d• •
due .io the high concent ration o f PHE in APM. Wll~n th e rat con sumes" one test
loaa of AfM in -water.(200mg/kg), TYR ~d. PRE are.aignifica.ntly incre~ed (th e
means are 139.7 ±.8.4nmol/g anU5.S ± 2.3nm o!/K, respectively), as compared
. to wat er ' in tak~ (54.4. ±. 2.7nmol/g,.n d 31J.3 ±. O.O~mol/g respectiveiy), an d TRP
and 5-HT 1~O.3 ±. ~ O .6nmol/g and 484 ±. ISnmol/g, respectively) remain '
uaalte red in \he rat bra in (Wurtman, l Qsab). Fernstrom,-{erilst rom and 'Gilli~
(J083) showed t hat bra in J~vels of 1'RP significantly decreased and brain levels'o f
TYR .and ' PHE significantly increased :t0miD" and 6OrJ!.i~ , after intub'a tion' o f
200mg/ kg of AFM administrat ion. Howev er, the TRP changes were lesS reliable
tha~ tbe changes in'the levels or1>HE and TYR.
.:~:
-..~,~
- ~ '_J"J : ' . -:- _ ." ~ ":. ,;, : .:, :~" l,.'-_
The 'r a.t e of ~HT IYDt llesis in th e main~-.uan" brai:i is extitm~ly Hnsit ive tO~ ,' ,
·TRf su p ply. A chf'Oll.ic lowerin-If; orb~ain iuP ca~ a. loweringi;>f .5-HT beeee
th ere a p pears 10 ·be DO lon g ~r~ eompeDn~ry . mecba.Dis~ _-f~; · this ·
• I . - . , •
n eurotra.ns mitle r (r~nstroin, 1086 ). Therefore, any than ge in brain TRP lent!
t hat may result from chronit APM osage will c ause & ch ronic cban ge in S-HT
~nil~ili~1. De la Terre , Kaw&Da.ga u d M uUO"a (IWqJau~ested t h at tbe braiD. ~
HT syst em playa aD im porlant role in ep ileptif or m seiaure acti v ity. H~nc~ &D
a lteration in this aystem may ac t ually cause I chloge in eeaere ac tivity. Racine
and Coscina (1070) demo nstrate d that a decreas e ill 5-lfr ta n- Inereee seizure
s usceptib ility. T hey found tb·' t the ener-deeher ge thres holda were decreased in
th e amy gdalA~t Dot the neceo rter af~er ' r; he lesi~Ding. Th~e ra ts ,190
r equired fewer a.mygdalo id .~i~ul~tions to develop gc~cra.liztd eonvulsio~s. Henee,:'
th ere appears to be AD inbib itory role for 5-HTin kiodling. There fore, a d ecrease
hi S·'flT ~ ..{es ult of AP'M eonsu;ption may m ake bra in tissu~ ~re excitable
and this excitabili -ty wou ld beeven more pronoun ced in: children 'or young rata&9 •.
a resul~ of their re~Atively immatur~ BBB . ~
';1
10 Igree~eot with the erred~ of S-uT":-mOdul&tiot,-YuwiJff"inirtootUt\1Q8I~~
sh owed that if hooded . r~ts reeeived a.da.ilY 51I~ple~eDt ·of Sukg (of booy weip i ) . _.•--' _'. :\~
of l-PHE the ';eu sero tooin ~otent ' in plasma ' deeeeeed sigoifi~aDtly ~ _~~
compared to 'D~n:-~nppleme~ted r~b. Ho~ev~r , it ,WUDot~ that the lD.im~l! that_- - .::r
were lid l1ie l-PHE diet ate- less food t batl the DOD-su pplemented an imals. A
seeond . study b y Yuwiler ' and Lootti t 1 1~6f) , ill w hiebtbe uimals were
8uppl eme~ted with t.8g/kg (of body w eight)of l-PHE. showed DO lignific~Dt
decrease in serotonin co ncentra t ion or in: the ·am ount o f food ingested. TrJ;;tt
(,,is) demonst rated ' hat PIlE ' .;d · s::m . how eu inverse [elmcst 110",)
r elation ship ;egar dingle i.zu rc.\~everity i~ mi~e. He ?evised a 3 x 3 e:t.es~gD-.wb } e he
used tb r",ee levels of 5-hydroxytryptophan (a 5-HT precursor ] (Omg, 0.75 g ~Dd
'l.SOm~) end three levels ~ on·PHE 10%, 1% ADd 2% of d ietary PHE suppl ment) .
-It WAS Io uad ~hat u~ tbe,.,Iev~Is'" of I-PHE iD~reas~ 10 did t~everit of the-·
. audiogen ic seizu res. Wh eD the h igbest d oses of both cbemi~als " ere sed the
~everity. ot,tbe seizure, was minimal. T,hehigh dose 01&-b;droxytryptoPhan paired
with the 10w-1-PHE dose alsoshowed a minimal seizure. However, when the
anim~l receiv~d tbe lowest &-HT dose and tbe highest I~PHE dose tb'e. ~ebure
reached a maximum on the severity scale. Tbis demonstrates tbathigh doses ol !jo.
. ' ~' :
' hy droxytryptophan appea r to offer ptotecti on again st audiogenic seizures. Tlie
se izure se.!eri ty ap pears to be inversdf relat~d to the &-bydroxy tryptophan
dosage, and lLS I-PRE increases and 5-bydroxytryptophan decreases the sei zure
becomes mor e':sever e.
Phenylalanine Modulation EfTeete.
"'-
PHE can also hav e a dramatic effect on plasma and brain levels of amino acids
and neurotran smitters. When 200mg/kg of AJ;'M wee adm inistered' to rats by a
sto mach tub e, a \two-rold increase in brain PIlE levels ceeurre d (W""r t man,
1983b). This errect WlI!J doubled if tbe ra~s j eeelved both APM (2'Omg/kg) and
glu cose (3gjkgl: 'The ArM. alone com plete ly blocked tbe' normal ris e in brai'n 5.-
HT prod uced by carbo~Ydr~te consumpt'ion. and tbiS reductt~a~y .' ,., ,'
r,acilitat.e,dbY~I~cose , . ~ .
O n the othe~ ,band, Stegi nk, Filer, . Jm.e~MCl?onnell (l ing) found t~.at the
maximum plasma. and erythrocy:te PIlE lev els following ing estion o r 34mg/kg or
APM in orange juic~ by adul ts and adult PKU ?eterozygotes.wer~ slightly above
values not ed postpraBd.iall~in the infant and adul t. Kceh , Schaeffer and .~~aw
(1'd76)sho we!tba t ir 34mg/kg (or body weigbt}or APMorthe equivalent I· PilE
was given to PKU homozygotes a.nd ecrmel cbildren in on e test day the serum
PIlE level was lIign ificantly' ·increase d.ror..those with PI<U, The adult PKU patient
appears ,to blable to met':,boliz'e t ,bedose o~AP~ giv~n here with no apP8:!ent
p~ob.lem ov er.a ~~y ~er iod . ,.,Caballero, Ma~o~, Robr, LeVY. sud.W.· u~t~an;gS6t
showed that humans ingesting relatIvely jew levels of APM (Iomg/kglJ'wed a
significant increase in ~Iasma PRE Ihr alter ingestion. This pattern was also seen
in : PKU carriers . They also 'found that the rat ioor PIlE/large neutr~amino acid,
, . . ."
... ". ',
. , ' ' , ' , . ' , . '
At a; u~known levitbe P HE,conc ent;ation in the brain , _ c~n',become '" toxi~ as:
ha~pens w"ith PKU (Wurtm~n , 10Mb). Th'e toxic , ie~e l ; eeeamis take~ : ~ be
20mg/lOOml. Cadell, Harlow and'Waismao, (U6 2) rai sed mo~keys r~'m'birt~ o~ ,
a I-PIlE rich diet and since the anim alsexhibited th e same sYmptoms M ,a:P KU
ehtld. jheywere called PKU monkeys. Hence, even t.baughth e anim~ls ~PJlar~ntly ". ,
had "the liver enzyme at birth the high level o r PUE appeared to.eithe r inactiv ate
the enzyme ~r 'make it l:sa effieie~t ~' that Pi<Uwas ind~c 'ed , Fort y' percen1 \or
the PKU an imals~xhibited grand mal convulsionsandt his s uggeilts th:L~ cOli~~ant
'exPoS ll r~ to poE may j'nduee epiept ic seizure!!. UntreatedPKUb"aIso ~orrela~d' : ' ~
wi'th ' intelligence(Fisble~':Azen, Hende~n .aDd hi~d~a~, J987), TbeY" c~~p:~red , '
33 PK U children wh o from birth h~ been main,t~ined on a res.mete d P,f{E.di~t ~
.:
) ' . /
waS ~jgn i.fiean.t1y inc rease;3. .in .these' two groups.
PIIE/LNAA rat io po tentiates the eftec tl ~r APM on b",m F'lIE: 1""Is:Th,,,I..... .
imb&lant~ i~ t he plasma con~entra.tioD of .P lm 'w,¥! lea~ to marked changeS in _
trans port an d brain concent rations o f &11 co mpeting ,amino aei~8. The probl em
with the abov e stud ies is th at they only used one tes~ load which may oot be
geDera li~8b1e since alt eration s in plasma am ino acid levels mAy bav e been &ll '
immedia te- r eaction instead of what one ex pects to see in the ·long. te~~. :~·Au
indiv idual w ould Dot consume this d~ge in one sittin g in the ,tea) world: nor
would any equi1ibrit~m mechanisms hav e come in to play to retl rD con ditioDs. ~
ecrmel with the time frame between ingestion and me asurement in.these DDt t est r
load studies. The possibility or a cumulat ive ,effect of AP M' afte r repeated,
habit~al, exposure b as been explore d by Ma talon, Michals, Sullivan and 'L.evY
, (lgS7). They found tb at normal adults ingesting APM(50mg/k g or lOOmg/kg) for
12 weeks showed significant ly highe r urinar y and bldod concentration or PHE '
metab~Ii~~s as compared to th eir baseli~e i~vels . The 'PKU, het erozygot es,also b~d,
significantly· higher . b~ood en d-urine conc;rit~a:ti~n or the " ~Im meta~liteS ' ,~'
compared to their'own baseline level.Js well as ',to th e'levels o~t ain~d from' th~
normals upon repea ted ,expoSure Co' AP~, Hen ce hab itu'al,us'e l)~APM do~:~aUi;e 1,.
an.elevation in PH~. 'tbat mayc ause a prolonged decre8.'l~:in:..b~ain 5-HT.:~ \ '
tor ten years Wit~2 PKU children who d~c~ntinue\their restricted PRE' 'diet
after six _ years.:Th~e groups were compared on stan dardized testsor intelligence,
langq age , a.b ili tl~· school ach ievement and per cept,!-al skills. They found that the
intelligence , spelli!,1g~ea.ding scores were higher Ior children inaIntai~ed on I
PRE-restrict ed diet .--rhis pr ovidesevidence to caut ion agains t the uee-cr APM in
specific populercns such as , PKU children lI.11d Pmt het erozygot e pregnant
women. However, many pregtlant ~omen do not know ir th ey are PK U
het er orygot.es, theref ore all pregnant women sho~!d shy away from roods ~hat are
documented to possess an excess or PHE: Th e chances of having a ~aby with
indu ced PKU may ~e increased since the' fet us may be exposed to abnorma lly
high levels o f PHE.
- . '
The above eViden~e illustrat es.that APM in take.affects plasma and erythrocyte
J level~ pf amino' acids and neurotrans~itter. ,levels.' These .ejtecte on
neur otransmitter levels could cause' an altera t ion in the excita bility of ne.uron s in
the eNS.
As,~"'Add
Oln ey (197 8) hypothesized that the exci tatory (.lllri z\ tion) "~echanism
'i _. _ . _ ' .~_up~di~ th e. neuroto xicity of amino acid exc ltente, and that tilt! tox ic act io n is
, . mediated through Glutatna t; (GLU) or ASP excitatory receptors on: the
. dend rosorI;;al surfaces or cen t ral neurons. Th es e amino acids enter th e brain rather
slowly and even thou gh they are meta bolized ve;y rap idly, competit ion and Bell-
• inhibition can still be de~onstr~ted by sen~iti~e techniqu~. GLU or ASP ~re
effectiv~ in d estroying the ci rcumventrieular organs (CVO) in either idant mice
or rats it A'dO!le as low as ~.5mg/kg· is inll~ted. For erempl e, Perez and OIn ;y .
... (lg72~' found th~t- GL~/b"t ~!- . ~dminis~d 8ystemiea~IY to ~day old ~ice ,
resul ted .in . a significant inOux of ami~: a~s \ into specific' brain . regions,
p~!~icularly th e.Cv.O. The eva, even in an a~ \! are' areas in·which·the BBB is
rela tivf!ly m ore perm eable th an in other a reas, however, they are even more J
median eminence, the sublornical 'o rgan, an d the are a postr ema. It
iha'ttb" BEIBin the immature'r at brain ill very permea ble and allows ..
to pass through it. AP. the BBB, matur es these. chemicals are"
excluded. th ese chemleals only circula te in th e cvo. However , GLU
end ASP may a tta in hy perosrnolar concentrations ~n the blood, ther eby damagi ng
tb~ BBB. II t~i8 occurs toxic l.evcls'oLGL...Y and ASP may enter additio nal bIfiD
regions. Severa.l excita tory amino acids, inclu di ng L-glu tamate, N. metb:ff.D-
" aspa rtate, and L-ASP I pr oduce convulsions in mam mals, providing t hat th e blood-
brain barrier is rel ati~eJy inefficient, Il8 in immat ur e anim als (Ch eema, Malathi,
Padem euebee, and - ~arma,\1969), or by-peeeed by the route of administration
(Cra wford, }96 3). Joh nston (1973) showed t~at t he above exeita n t amino acids
prod uced eo~v~lsions i~ ID-day old ra ls l when injeet~d ' intnperitonea llY. These
convulsi~ns we~e characte rized hy repeated to n ic "seizures " ioval.vin.1!: all limbs,
bead 'and ta il. Convulsions lasted several minutes. The tim e of onset of seizures
\ ' ~ , .
was dOse ,depen dent and was used to compa re ,the rel ative pot encies ,of the
excitakiry ,aminb acids, ·T his ~tudy sugg~ted t~ ~t the 'con~uisions ' in ID-day.old·
rats were directi; relat ed to th e ne~~oex~itato~'Y- pio~~rties of thes;a~iri.o acids:
The ,view' takeJ by ' Johnston . (~g73) ,--was th~t 't1i ~ convuls~t: ao.d excit~t
act ivities of thJ e' acidi c amino a~ids have th e sam~ basic mecha ni3m, . l.e. the"
d ir~ct' depolariZB.~ion ~f "central ,neurons. Weitz;"Merlo~ , 'Am ir and Reisner '(1081)
, ,
suggest ed that increased brain aspartat,e levels ma.y bav'e an epilep togenic effect in
ne~bo" buman.: They found 'Imt' (ASp levels in l",eh" l-\p in. l fluid in .n '
infant who had in,trac t able seizures. . \ ' .
Alt hough yo u ng anima~ are mor e vulnerable to ASP-induced brain damage, this
damag e also ,occ~rs in adult ' ani~als (Olney, ~(76) . 'P rice, Pusate~i, Crow, "\. . .'.:
' Buchs~aum, ' Oln ey 'end Lowrj (1084) tre~ted ' adult mice intraperiioneally with
ASP at one or sev~al dos es (0:47 to 3.75mmol/kg) and ,30~in later gave th e 'same
d~e o.f~p sUbc~tane:usly . The y f0'!rdlthat, in. ~he 'CV o. r.egions ~r th e brain
the ASP le.vets were 1.5 and 3.0 times . ~bove th e levels "in uutreeted animals ,
!
following the lowest and h~~hest doses, respect iv ely. Th e tissue ASP levels
remained unchanged in non-CVa brain regions.
Millan, Meldrum and Faingold (HI86) found that a source of ASP [Ncmetb yl-D.
aspartate (NMDA» , when injected into the inferior colliculus, c~uses ao ioer/ Mc
in audiogenic seizures as measured by the animals response to high int/n sity
acoustic st imblat ion. Tbis study.showed that high levels of ASP (in the:{~rm of
NMDAj were responsible for,the increased sU9cept ib rJityof an anim~l ,to have a
seizure. NMDA is also a potent convulsant when injected i~t'~ the rat
hippocampus, amy gdala, eonexand cerebral ventricles (T urski, ,Meldrum and
Collins, 1085; Zac:tek and ~e, 1082). However, whe n NMDA is iDjccted into the
ventral mid-striatu m it preven ts amygdala kindled .seieures in r&ts. Since APM is
a source of ASP it is impor tant to de~ermine if AP M has ant neural excitotox i ~ :
ellectS. It has been argued that GLU and ASP are safe fi 'd additives,becaus.e.
humans have been exposed to _these compounds in;bn e form or another for many
years without 8us~ain ing apparent harm. However . GLU and ASP-indnced brain
. damage is a silei\t phenom'enon and neuronal degenera tion may be quite extensive
before behavioralf att erns ar e disrupt ed (Olney ~ 107.8) .'
. . ,- '. .""'* .
Moreover, approva l of unlimited APM use iii ch ildren may not be justified.
D.lney (1074) found that when children ingested GLtJ and,APM.'~hey had. a five to
six fold increase in plasm a levels of these two che micals. Stegink, Shepherd,
Brummel and Murray (107 4) ha.ve estimated that ....a six to .teu fold etevation' 01
plasma GLU + APM is required to destroy neurone in the 'infant mouse
hypothalam..u~, High doses of botfi A!f or GLU (l ing/gm of b~y weight) are
capable of. inducing retin~l and hypothalamic demeg ein fet al and neonat~1 mice
{Olney and Ho, 1970 j. GLU and APM appear f.? have an·additive erfect 90 that
only-hall the dose ( O.5mg/gm ASP + O,5mg/gm GLU of bod y weight) prod uees
the same hypothalamic and retinal d~mage. 1D agreement with the above studl
Daatees, Finkelste in, Ste{~k and 'Apple.baum (1"Q85) ~ound t~at mice receiving ·
. 250mg/ kg (of body weight] of both ASP or ~LU de veloped neuronal necrosis and
,\ ~
\
"as t he doses of bot h ehemicals incre~ separately 80 did the &everity Of t he
, .
necrosis.
\
T he\dministralio n of large amounts of ASP and/or GLU to neona tal rodents
h.., ' ntQ.uivoully be en I~own to produce elevated pl..,ma ASP aDd GLU ·
eoneentrationl Ind by potbalam ic aeuronal neel'O!lb (u SHU abov e], However , the
ability of t hese amino acids to produce· neuroual necrosis ' in the ~nbuman
primate is coniroYers ia.l Olney and Sbarp (l Q60) and Olney and Fe igin (1072)
reported neuro nal necr osis in inCant nonhumeri P~&tes ci~en l&fledoses o~ GLU.
Cont rary to this, R eynolds, Stegink, Filer and Reun (11l8O) (ound that infant .
monke)'! receiving 2gm /kg (of body weight) of APM or 2gm/ kg (of body weigh.t)·
or APM plus 19m/ k g (or body weight , ' of MSG (m onosodium glut amate • a
.-
gluta mate source) d eveloped no hypothalamic d amage. Reynolds, Lemkey- .
Johnston, F iler and Pitkin (1071), Stegink , Reynolds, File r, Pitkin , Boaz and
Brummel (107&)and Heyward and Worden (1070! did ~ot_ find ne9ronal n; crosis
even when plasma ASP and GLU eoneentretlc ee may bave be en peat1y elevated .
These [IDdings 'lu'ggf9 t' that there ,is a definite epeetee difference. Hy~thal&mie
damar;e is not- pred ic.tabl~ in DODb~maDpri~atesa5 ~is i; rodents. Ginn th ese
results the den lopm ent 01 neuroDal necrosis depends OD the animal model beine
utilized.
p Aapart am e aDd Sels orea .
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thresholds in the genetically epilepsy-prone rats used by Jobe, Ko end DlI.i1ey
(l gS4). ThiS suggests that exposure.• to· large amounts of APM may ultimatel y
,decressl: br ain levels , of norepinephr ine and adversely arlect some people
predisposed to eeb u r ee. Ooneublcne were observed in a It udy in which monkeyl
were ' led ·3.6gJ.kg of APM lor' 30 weeks (Health and ~e1tare~~,,&da, 1081~
A!J shown above, elevationl~ and ASP (compon ents of APM) and
. 'I lowering 5--II T incre ases the~p;obability of seizures. Wurtman (1'185) showed th at
- ,diminished braiD levels of eatecholemines were _assoc iated with lower seizure
\.
, ~\
J.~~>,S
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However, on e criticism 'tlf this study was that animals were not given free access
to wat er. T h erefore, it may D~'nave beee th e ArM ~bat induced the seieure b~t
plasma. hyper osmolarity, prod uced b y dehydration, that ma y have caused the
seisu res and alte~:tions in hr.ain elJiriea l activity. In a. similar st udy by Reynolds ,
Baum an, St egiak , Fil er aod I1e!du (1984), monkeys received-levels of AP M up to
4g/~g for 270 days. Water ~ continuously availa.ble. No convulsions wer e
observed in th is study . Reynolds et al (1084) co ncluded t bat co avelsions observ ed
in th e monkeys in t'he previous st udy were due to byperosmolsn ty snd/or
byperaminoaeidemia induced by Iorced feeding.
"
P int o and Maher (19 86) ha ve rOUD~ that doses of 250, '500. ~!!d 750mg/k g of
APM administe redo~lhr before pe~ylenetetu.lole (PT Z) W Il.'I eubc utanecualy
administered to mice caused no chan ge in th e PTZ C D50 ( coneeDtr~tion able to
induce seizures 50% of the time ). Ho~ever, a t l00Q, 1500 and 2000mg/la-gof APM
the PTZ COSO was s ign ifican tl y lower ed. Seizure;!!. occ u rred in 75,8 1 and 100% ,
respectively. ·T bb st:ud y demons tretea that AP'M ~oes a:lter'hra in e~dtability. T~e
. eftectsor.a high conce ntration of APM, in plasma, on m.ice are unknown. In rats
the dosage reqIJired to produce equiva lent plasm a con centra ti ons to human~ (8
dosag e of 34mg/ kg 88 defined as the ' 9~ per centile daily human dose (lfattan~
, ,
' Henry, ,Montgomery, Bleiherg , Rulis and Bolger, lU83)) is 200Jng/kg of' APM
(Stegnik, Ko~ht Blask ovics, Filer, Bak er and McD~nnell, Ig81). Mor e rec~nt
luera ture (WurtmaD and Maher, 1988) indicat ed that SOOmg/ k g (of body weight)
of APM in rats may be required to pr oduce the same erfed in plasma as 34mgjkg
,, (of body weight) of APM does in humans. AU APMdoses that have been te~ted
ill hum ans rais e plasma PHE relative to'TYR .-The PHE /TYR r; tio in plasma of
rodents is dirferl'n t to th at of humans , following PRE ingest io n, because hepatic
PHE hydrcxylee e is m ore act ive in rod ents. Thus there is.no simple comparison
for dosages of PRE between rodents and humans becaus e equivalent PUE levels in
plasma yield unequal PHE/TYR ratios. Henc e, it' may be m ore reasonable 'to
determill.eAPM doses th at raise plasma ~HE in huma ns to th at equiva lebt dose
... that raisee t he plasma ill rats. Tberef ore, the dose u sed by Pinto an d Maher
(1086) .:n~~ .or ma~ Dot\an been re~"'iable u~ a ~ore eompr~hen5ive . ~~Y~Ui ·
of plasma ~~els between' species needS' to becompleted. A mare senllili~e I~ni or.- •
~%ure ;l.hreshold ' determi nation may abo be required. Nevins, ArDolde and ' .
Haigler _(1m) found tb at APM at doses of ' SO or SOOmc/kg achirll:list~red by
gavage .0.5, I, or 2hl1l before PTZ.induc~ M!izur.. or ECS i.o mice produced no
effect on threshold. The thres'hold wu meallu~ed by t~ presenee or ~bseD.c·e or
dODue~ (PTZ) or J:uS' fBCS) th at' was' reeceded and"the percent. 01mice having .':
. 5ei%~res in each group Wallcalc ulated. The dirr:rence between tbe two studies
indicates a poeeible dosage d itfe~Dce and it Wortm au' and Mahe~ (loSs)
ar~ment 'is correct than the d9llage used in t he Nevins, Arnolde aDd H~gler
(lgS7) study was dermite iy too small.
• 'e •
Hi",h APMdoses were found to' pot entiate seizures in rodents, wheth~ tb e
seizures were noke<!. 6y drugs, electroshock, o~ inhalatio n of nuorothyl (Maher' .
,nd Wur;tman, Hl87). Tb~)' ga~e llllma.ls doses of APM Yal1ing""iom.2sW.gJt g
to 2000mgJlr.g o ne hour before animals were.given the.CD W dose atPTZ.They
fouu"d ihat as the"dos~ of APM 'incRp ed the ~um~ of aD.i~~ th~~~ sei~ureS-'-:"
increrised (50% io 100% , r~' Iy for the abaTe doses). ne1 "tbeng&v~ .
another ~p o r animals 1000 Uil of AP~f .a.nd ch~g~ th~ d&leof PTz.Th ey
found that a lower'dose oirT ~~;requir~ to procluee seizures in APM ulmals,
Th~ enh~nced sll5tept ibilitJ.., PTZ.~ductd seiJor.eswu alsosee~ among mice
pretreated with &D equimolar dOSl'! or: PHE before rd:eivinl PTZ. Whea. llliRt&b
were gi~eD APM and v&lin~ (la rge neutral amino acid tba t ecmpete witb ~HE at • -4
th~ pnnt the animah appea red ~ be protec~td ff?lD ;eizores. Th erefore, we' e~b .
co~clude tbat PRE trom tbe APM appears to bave a aeizurejn dueing ability when
. consume~ in large amountil.
~ .
Tb~re have also been a num!?er of APM-auggested medi~al c'omplaints from Uie ' v
consumer. In 1984 tb e Cente r ' for Disease Control peesent ed a pa pertb·Jl . ' .
represented over 200 people: T he complaints were'all very auhjeetive a~d dfn' rse.
They ' wer~: 67% rePor ted n~uro~c&l . and rm....io ral i ymptoin9 intludin g ',,:
..,::. :'.:..: .;• ....
. \
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dizziness, headaeh
,
e9 . and m~d alterations; 24% reported gastrointestina l
symptoms, 15% reported allergic type and/or dermatologi~al symptoms, 6% '
r~por(e4--Chang~ in' m~nstruaJ patterns , ,and 9% reported other symptoms. The
. Center for Disease Cqntrol concluded that these' 8ymp~~were not related to
APM consumption. B radstock, Serdula, Ma~, Barna rd, Crane , Remington and
Trowbridge (1086) also found that people repo~d a numbe r of complain ts with
regard .£0 APM ~sage . They found that o~t of 517 reports, 6T% had
neurologicaljbehayioral problems, 26% bad gastrointestinal problems, 17%
reported allergic reactions, and 6% reported menstrual problems. 'They also
reported t~at in general these..s,y~ptoms were unrelated to A:PM consumption but "
they do state tha~ some specific eubjeete' symptoms appear to be related to APM
consumption in commonly consumed "~moun ts. ' Walton (lgS6) looked at a ease
study .of a 54 'year, old woman .wbo had no previous history of seizures. This
woman bad a seizure and manic' episodes upon consumption of large amounts of
APM. ivh,en t.heoAPM was ;liminated f;o~ her diet eo were the manic"episodes
a~d no~ore seizures 'were triggered . A child developed unexplained"Heiz~res a~d
it was 'found 'that the ' m~ther had weaned her child trom milk 'to "diet Kool-Aid
(Wurtman ,i087). Even though these ~ases are subjective .and may be ,iritplicating
the wrong product it is suggestive evidence.•
In s~,ary, th!. eV ide~ce in.di~ates that ,the ,metabolic products of ~M can
,alter eNS.excitability end may induce convulsions. These data raise two very
.important issues.that have Dot yet been approached in the literature -on APM.
The fi~t i~ what are the ellec: ts of APM on brain excitability. The second is what
are the efrects, of APM on persons who are predisposed to epilepsy. Th e first
questio~ ~iI1 be dealt with i~ this study .
Kindling.
. Kindling is Ii model of the development of epilepsy (Goddard.. Mclntyr e ,and
Leech, 1060). This-is a procedure where low intensity stimulations, repeated daily, ~ .
"\
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to cert ain bl~in 8iru~ tures causes a progression of th e epileptiform arte~-diseha;ge
(AD) Th e IDltlal stimulation disch arge, it it exceeds the aft er;dlScharge threshold
' (APT), contin'uefl foe a duratio n of lOs {Recine and Bur~bam. 1984.~, and th e
be haviora l c}:lara.eteristic th at 'accompani es this is behavioral arrest . With repeated
stimulation: the AD increases in amplitude. A9 stimulations continue the ,/
amplit~de of the wave increa..<Ie9 , the -dur at io....D of t he AD increases thr ee to ten
~rold and t he wave ' form inc;re'llSe9 in complexity. Kindling pro~esses behaviorally,
ItS well 49 physiologically. Physiologically , excita bility ca n on ly be alt ered by
' ind~cing current intense enough to e~oke en AD. It ~ the pr oduct ion ~r AD 's' th at.
makes th e .procese of, kindling possible. Animals undergoing: kindling ' pr oceed
thr ougb r~v~. beh~v ioral stages: Stage- I, mj)Uth move ment (chewing and slhac king)
began to appear , Stage-2, mouth movemt:nts en d head' dOIlt~s, Stage-3, mouth
movement , head do nus and forelimb dOD.:!S, St age-40, mout h movement , ~~ad ,and
Iorelimb c~on.us; and. rearing , an d Sta ge-5, total loss of' postural cont rol (R acine,
10728) . .Th~e progressive stages of behav iOrS a re comparable "to complex-putia l
epilepsy . ( c~.ewing.. ·h~ad.~od'd ing) to tbose eeen ~:' te~poral (lim~~~) lo~e . e'Piiep~:
(oyert jo nie-elonie ·seizures),(Sta.ge-5 seizure 8S defined by Racine (l'i172A)). These
chang~'&re'permaneDt (Goddar d , ~cIntyre and Leech,1~601 . '
It : is not t he st imulati on itself tha~ causes kindling,but th e prod uction .of AD's .
ADT's ca n .be .Iowered ) n t he hippocampus an~ amygdala by thedail~ 8ti~ulation
t hat is de livered to these are~ to produ ce kindling (Racine, 1072A). ,T he area of . \
in terest in t his st~dy is area 'CA:l of the blppocempue and is one of t he arau 'in
t he lim.b i~ system ';h ere te mpora l..iobe epilepsy ori~n"td (Girgis, 1082), .
Kindling itl!~1f alters brai'D tissue excit ability. Susceptibii ity' to kindling is a ,
rerlection of tissue-exc'ita bility ~ T herefore , if brain tissue excita~i1ity is increased,
kindling sh?uld be enhanced. ~T ·may be used>.to assess local 'ec nvulsive
ex~itabi}i ty , ·the. effects of dru~ on ~his excitab.ility ffi.aY" .be me.asu~ed ei!her W~th
respectpoacute drug etreete or Wit h respect to rat e or .c~e or '~T With
• \ . " .() ';'epeat~~ stin;au.latio~.• Th us ki~dling is .~ u s~rul procedur e 'ror studying br~· ·
, excitability,'
Present Study.
18
Th e amount of water each animal consumes daily WII.S previously determined to
be approximately 4~50m1, hence animals will be given SSml. Animals in the
'present stu dy will have free access to their drink ing boul e with ssweeteneds
wate r (55ml) or plain wat er (SSml) in it. This method of free access to a liquid
was chosen because it provid es t)le better ana logy to a hum an cODsulJling APM at
their leisure. We went to mimic the erfects o~'APM usage in humans to ra ts.
Humans have access to a liquid the same as the rodents in this 'study do.
Most of the reseereh on the APM issue uses the method of gavage. This is a
good method if one wente to determin e the immediat e effects of a high dose of a
chemical. ' Howev~r I when st udyi_Dg a daily consumed chemica l t hat 'v irtu&1ly has
replaced carbOhydrates i~ many households it is more benefieial and advant'ageous' (
to laavc Iree accesi:'This ;ncthod eliminates the stress, both physical,and mental ,
.~~_-,_-:as_ ,--:-oeiated with gavage, and, it mimics the constant alteration or blood amino aCid
levels that accompany the many APM ingestion sessions during the ~ay Ior a
hum an. Furthe rmore, the errect or a dose or relati vely high. concentra t ion at one ',
time in the day may be dirterent Ircm the same concentrat ion ingested during-th e
norm al drin king schedule. ' ;
\
Ther e are also many different protocols that eould have been implement ed for
tbe present study. or the many two will be discussed. In the first one ADT is
assessed on ~ay 0, dey'I (first day of APM ingestion) and day 7 (last day or APM
ingestion). Sta rting o~ day 8 the anima ls:are st imul.ated two to th ree times ,a day
until they are kindl ed. Th e second design would be identi cal with th e exception
tha t APM ';o~ld~ave been continued until the ' animal was kindied"'Th~~ i~o
designs are very different in terms of ~he issues, they .eddrees. Design 1 addresses
the issue or 'a perm anent or long-t erm alterat ion induced by APM' aft er AP~ had
been discontinued. Hence, are there any perman ent consequ~nces as a result of
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previousAPM ingestio~; &esign 2 &Dswen the questionabout e'!,ects d~ring usage
of APM . :The hypothesis being tested in the present ~tudy is does APM iDg~tion
cause a permanent erred in brain excitability? hence the method of choice here
was design 1. U' one wanted to determlue if APM causes a.tra~ange in
'excitability by using desip 2 you would ,t'i11 hav e to use de9tgn I to d'ete)m ine ~
this excita.bili~y alteration ls'per mauent or tempor.;".
T he kindling method y "~ensitive indicator of, brain excitabilit y and is th e
preferred meth od implemented when deter mining seizure thresholds.
T he present study Used thre e gTOUPS of animals~ 0 group (animals received
water), 200 group [animals received 200mg/kg (or bodr weight) of APM in.water) .
and 800 group (animals received 800~g/kg, (of body weight) of APM in wa~er) .
AU &.n imIL19. r~ceived the specified liqu i~ for seven days.~e·d0ge or2oomg/ kg (of ~ ,
body weight) of APM wee chosen because U it is the....f..HE and TYR sum that is
im~rtant th~n this dose is surficient to produce an equivalent 'P IIE e le~ati~n, ili~··
~~. pleeme in ~a" i! humane ;on, um, 34mg/k g la! h~~y w, ight )·o!~M. H~W~V.';. if'
it is the ra tio oCpill to the·l a.rge neutral ..mino acids that is import ant in both
hu ans and rodents then a dose of 500mg/ kg (of ,body weight) ofAP~ or more-is
required to increase P HE subst ant ially more than TYR in rat plasma. Hence,
~ Boomg/ kg [of body weight) oC"APM WIS chosen: If there WIS a permanent change -.
-- '--,-
. in bra in excit ability ' at 8OOmg,~g (of body weight) of APM (eedetermined by.
ADT assessments and rale of kindling) but not at the 2oomg/kg (oC body weight)
of APM level then the critical dose could be determ ined. Ir there Was" no effect at
either dose, as co~p~red to the water group, then one can say that even tho.ugh
rodent plasma "equilibratea" humans in terms of the amino .~ids import.ant here , _ _
. ,AP M does not change ADT nor does it cause a Casterrate oCkindling.
• Purpeee,
S,urfici~nt cv!dence indicates t~at APM alte rs 'p l~ma and/or brain levels o~
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parti cular arM!acids (pim, TRY , ASP end TYR). All or tbfSe amino acids are
directly 'or indirectly related to-eeiaures as a result of their abunda nce ~nd/or
redu,etion due to APM ingestion.
Th e purpose of the present st udy was two-fold: 1. Are th ere any p!;rmAnent
effects of APM tha t cause animals to kindle raster even though .(pM eoneumpticn
has ceased'!'an d, 2. Do APM animals h,v~jmmedia.te , or s~stained lower ADT's?
In ot her words, does APM alter Ioeel eptlepuc excita bility and does prior ingestion
of APM arfed the subsequent u evelopment of a seizu re disorder .
. FI •
1t was hypothesized that~T would decre&S~ 'as a result or APM consumpt,ion
and that the animals receiving the higher dose of APM would kindle at a raste r
rate.
- 7
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Subjects. Fifty-eight male Long-Enos Hooded rats 125O<260g) were obtaiDed
from ChuJes River Canada and were hou sed in the '~imal "Cue . U~it at
Memorial University of Newfoundland. All, Animals were housed in groups of t hree •
Ref eage until two days pr tor to surgery when they were eeparated &nd placed in
individual cages. J::heir 'room was main tained on a ,bitted i2.hr J\bt, 12.hr dark
schedule (i.e . duk pencd . t 2:00 P .M. to 2:00 A.M.). All rats were implanted
with ODe bipolar stim ulating/ recording electr ode in ~re. CAJ of the hip pocampuI;::::..
Th e rats were randomly. Mlligoed into three groups ~n Day 0 prior to AnT
determination. Th e groups were: 0 Group (an imals received only water to drink) , .
200 Group (animals r eceive~ 200mg/ kg (0£body. weig~tl. i~'water to d~nk) a:Dd : ;"
800 Group' (animals received BOOing/ kg oC APM in water). Dosages were
determined by making:u p 200 or 800 m$/kg (oCbody w~igh.i) .0C- APM in SSin'l :oC·
wate r in ·~ idually Cor the . nfmals. Each ani mal 'wu .well adapted to the test ing '
. , . . , . ' , .
environ ot · before . sta rt ing the experiment" manipulat ion. During th is ",
ad~~b.tion r dur~ the amount or water th at ~~ rat cons~med w~:"r~rded.
This was do n to dete rmine the"g~nera1 amo~Pt or liquid 'to p~e the. ; nimw. All "
: nimak were pv ~ee teem to rood and a liquid. t~rougb.out the ~peri~eDt.
The amount of rood ana 'liqu id consumed du ring the experimental proeedu re was
recorhed daily to determiee ir there were 'any ,consumption differences. •
T here was a large atVit~on Cactor in fbis experiment . During the surgery one
. ao i~al di~d. Se;en animals died due to.. gast ro-intestio.ll.l illness tha t wi.. to tally
unrelated io the experiment (~ det ermined by a~ auto~sy) ; eieven a~im~ls were
sa~ririced du e ~/displaeed eaps (~ a ~~ult or the w~iting'P lll iO(i~Cte r the g~tr~
intest inal .ilIness' U; ensure DO sickness was introd uced into t be experiment ' ~nd
c elte r any var iablE!S); ~ne '&ni~a1 wis kindled in 't he BOOmg/k g Group alth ough
there W;\8 ao 'ADT round for Day '!. 'Finall,.-, live animals could Dot be k i~'dled " "
Four of i h'es:e.,an imals "had iD~rr~t pl~~~me;tlI and one ' bad th e ',cor red :
placement bu~ did not ·kin4Ie. .... . ',~. '
Apparatus. There was one....biP?l~r st imulat ing/ recording electrode Ior each
Animal Th e stimu lation administered and, the recording'S obtained were also
bipolar, Th e two tips of the hiPolaf elect rode were separat ed at a distance of
O.25mm, All electr~were tenon coated except for the t ip, The electrode
assembly and-th e anchor screws to keep the electrode in place were held by dental
acrylic applied to the screws and the skull.
Th e animal's electrode was attached to a Lafayette 60 H...sine wave st im~rator
(model no: 2Z408 ) which was connected to a 12V power supply that was used to
~rovid~wer to "the switching box:' Electrodes were disconnected _rr~m II
Beekman R411 Dynograph during stimulat ion by the switching box, Electrodes
' }Vere reconnected by ~ ch.~~gitig of the internal switch or the swite~ ing box to ..
en~ble recordin g of the electroencephalograph. The ' sti~ulus, was delivered by a
footpa~ that ~as also cO,!lnect,ed 'to the switching box and- t~e st imulator" Th e
switching box was in turn con"necte'd to a Beekmah R411 Dynograpb (ink-writing
po!ygra'pb) wh~re ~_ perma:ne~t copy ?f brain.~vity .waa recorded f~r later
an'slysis (see Ffgure 2)., The niter set tin,: of the dynograph was ~ 30D9 , the '
. amplifier was set at lmY/ cm and the pre-amplifier was adjusted lor animals,
r- -
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FIG URE 2: A block d 1aqram o f the appara tus used
in t hi s experiment .
Peceedeee,
Stereotaetle Bralo Surgery. Th e 58 animals were eees tbet b ed i.p. by
Avert in.i1.1Jl1/1OOg), :The bipolar electrode was stereota.ctiea.l1y i~planted~in each
animal;(under aseptic conditions}. Th e electrodes '~ere aimed ~t the CA3 /area or
the hippocamp~ with--cocir~in;t~ at 3.8mm D-V (Crom skull), 2.8mm posterior
(Irom bre~a), and 2.8mm lateral (Crom midline) (Kelnse, Racine and Smith"
.1084). Thr ee skull screws were necessary to anchor the acrylic head assembly.
Ingestion P rocedure. During 'the rats' recuperation born surgery the amount
or 'water each' animal drank each day was recorded Cor five days, This!as- don:
to det,ermine the ~mo'unt or liq~ id th~t had to be made-up, Tli1 rats drank an
average or 45-S0ml per day, Th erefore, each rat was given 55ml of liquid per day
soth~t ' aDY eClecton seizure th reshold could ,not be a~tributed ,tO_dehydration.An
rats. dr ank through e-verueel dririking tube with b~ll-bearinsf' atthe end or the
.spigot to minimize spillage. All rat!! were randomly assigned to groups on Day 0
and were given cr;~ access 'to a liquid thrbugh-out th e manipulation: 8 animals
received water, 13 animals received 200mg/kg 'of APM in water, and 12 animals
received 800mg/kg oCAPM in water. Animals received ,!,Cresh ~d ~t 11:00
A.M. every morning Cor seven days. The APM dose was determined tndividually
Cor each animal by ohtaining tha t parti cular animal's weight and multiplying it by
Ihe eoncean etion or APM used Cor that animal's group. The dos: of 200mg/kg (of
body weight) orAPM 'Was chosen beca~se it produces the equivalent pl~ma
amino acid ratio in rats (Hatten , Henry, Montgomery, Bleiberg, Ruhs and Bolger I
1083) as does 34mg/ kg (or body weight) DC APM in humans (Stegnik, Koch,
Blaskovics, Filer, Baker and McDonnell" 10SI). A very high dose. of APM .
. (800mg/kg (of body weight)) was used to determine if there wee any eftect on
seizure thresholds. If 'none are obi~ined , then it is unlikely that APM would aCled
convulsive excitability at the levelsconsumed by the general popul~tion
Box Ad aptatloll. AUrats were handled daily a1ter the stereotact ic surgery and
. on the te~th and ele,:enth pos\-O~rative day. they were each given 15min in the.
shielded test box. The rat wu free ~ move as much,u~ible and PO rewr.ding
leads were aUacbed. On the tweUth and ~birteenth post-opt'rl.tive d.Jys the rats
were again placed in the .ame box for 15min, however at tb ese times th e
recording leads were attac hed to the electrode.
K1Ddllng Procedure. One day after the ingett iou proCedure (the day after
,5,.A.
Thr eahol d Determln&tIQD. One day prior to the ingestion procedure (the
fourteenth poet-cpeeeuve day.Day 0)'the art~r"discbarge threshold (ADT),tor each
rat w~ determin~~ . The threshold WI S determined by usi~g a stimulus t!"ain or
60Hz sine waves or r.ieee durat ion. Threshold was determined totbe nearest SpA.
There ' was ' an i~ter.stimulus .jntervel or'~~n ' between ,Bt~ulus trains wheo .
determining , the thr eshold: Threshold w'u defined as the -Jowest~ tensity ot ,
stimulation required to evoke an AD..Th e th reshold wu again dete~mi~ed after .
the animals had ingested APM or water ror one day (OaY, I) and again on.the lut
day (seven day.) or APM eceeumption (Day 1).' Th is wu 'done to determ ine if
APM a1tect~ brain excitab ility immediateiy after ~gestion' or it the etrect may
. . ,
occur after longer ingestion, it it occurs at aiL G~up 0 served u a control.
. \.
~Iy \0 a generalized seizure tr iggering thr eshold (CST) (~~a, Osawa and
M~cbi. 1978) Wall determined one day arter \h e ·third sta~e-5 seizure. ,This W all
obtained by redud ng tbe kindling t t imulation intensity - by 5"A tor everr
ttjmulat~ eeseion to tbe point at which tbe ' stimula;ion was no longer tu rticieut
to induce a st~ge-S eebure. The int.etval ot ttiml ilat!ODS was 'tbe same u tht,t USed
Ior the kindling procedure. The CST would be the lowest. " in~e~~i.ty_ re~uired to
evoke a Stage-S seizure i~ a kindled animal and it waa dete rmined to the neerest
.. \ . . . .-. ;,."
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APM1rt been ecnsumed rOt o~e wee~) the m~ kindling ' proc edu re ~(~aeine l .
1072Arbegan fat . all animals. Tbe-~DK st imula tions were the same &S th?"e
used to determine tbrH~~ld . Th e intensity eacb animal received W I.5 th e lowest
curre nt required to evoke an AD aD. Day 1. T he animal WI,'J stimulate d two to
three times eYery day, with an inter-stimulus inl e"" of at least four houn, until
th e anima l exhibited thr ee Ita ge-5 C'Oni' u)sKlDs. Stag~5 eoaeulsions consist of loss
of postutal ~Dtrol and bead and bilateral ~loDu,. Th e CST was determined on .
th e day . subseq ue nt to the Iu t st age-5 se izure.
. . . f . ' i"
Pe ii'u s loD ~d Bistolou. All animals wer sacr ificed ODe week aft er being
kindled. The anima~ were perfusid tran se. iall)' wit~ o.g% buffeted saline
rO! IOW'1dby a 10% for malin solution. T he brains were removed and stored in 10%
tormal in Ior later sectioning. TlI.e tissue was rrozen in ~'propyl alcohol th al was
cooled in liquid Nitrogen. T issue W2S " eeetlened at 38 mr;r ons and every third
section was retained and staine~ ~ing a metachromatic creer1 viole~ procedure: ,
/ .
I
.i . I ' " ~. ::
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Only subjects with electrode pl eeemeets in area CA3 of tbe hippocamp us were
repo rted in the Analysis (see Figures 3 and 4).
Five animals were elimina.ted from the study because the ir ADT 'S were above
the maximum int ensity used for ADT determinat ion (400IlA). Th e animals that
did e~it an ADT initially produced a wave of high frequency discha rges
supe rimposed over a normal st imulus-response wave form. Thd amplitud e of the
discharges decreased gradually . and the AD's disappeared I(~20 sec alter
termination of the stimulus. When th is pattern was obta ined it was taken 'as the
AD on D'ay O.On Day 1 the AD was more defined and longe~ in lat ency. With the
progression or more stimuli over day~ the AD became more char~c . or a .
'eeisure sl ate with initial AD followed by - a progr ession of the behavioral
·char.acteristics through the eequeete 'ot sta ges (Stage-l through to Stage-5~e
Fi.gures 5). .
With regard to "weight differences, t here were no ~ign jficant differences in weight
gain between t he thr ee groupe over the seven days of waterf APM consumpti~n,
x" = 17.25gm, iSoo = 25.77gm, and x.oo = 21.75gm; [(2,30) = 0.76, P > 0.05.
Th is referre,d to the; wei~ht e:~n between O,aY8 1 and 7. Hence APM animals did
not gain any more or less weight than tbe water animals. Th erefore, any
differences found in the dependent var iable were not mediated by ~eight
dirrereeces (see T able 1).
Th ere was also no signifi~ant dirre~ence in food consumption between the thr ee
. .
groups over the experimental manipulation lXo = lOO.38gm,~ =: i 7.15gtn,
and~:=: lS0:0gm; [ (2,30) = 0.34, P > 0.05). Heuee, drinking APM in water ~
does not decr~~e or increase roodinta.ke in rats (see Ta ble 2). •
\
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/.F lgure 8: ,
Distribution or or electrode tips in the hippocampus. Blocked
area in CA3 indicates the conccnvatioD or the tip:l. ~
..
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Figur e 4 1
Photogtaph.cf a brai~ slice sho~ing th e electrode' tip within
Area' CA3 or th e blppocem pue.
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Figure 51
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Two examples of the prcgresslve increase in the durat ion of .
the a1ter·dis charge .t hat occur as an animal comes clo ser to
being kindled .
A I Th is shows the a fter-disc harg e exhibited by Animal 41.
BI T his shows the after-disch arge of Animal 19.
.. " . - ;~ ' .
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Table 11 One-Way Analysis of Variance to compere weigbt gain in
subjects ov er7 da ys ofAPM inges t ion.
- ---- -- --- - -:"------- - --...--~-------------~-----------.-----7
Boure .
G(GROUPS)
ERROR
df
30
ss
354 . 0
7188 .0
••
102. 00
238 . 93
0 .75
'. '
Table 21 -, One-Way "Analyele o (Variance to compare rood intake in .
Bubj ectsover. 7 daya or APM mg estion.
,;. ----~-_._----_.._-..;-------_.----'---------_._----------,----. \
Source
G.(GRDUPS)
\
ERROR
df
30
..
842.liJB
28327.150
. lIB
· 321.49
liJ44.26
F
' , p." If
:.::::::;:'::i.:,:7~":..-:::.:,;TY;
= 1.03, P > 0 .05,). The total amouol thal ao animal co uld consumepe r dayw~ l
5Sml. Th ere was no s ignifican t differe nce between groups over the'sev en days.
Hence, all groups drank the sam e amount of liquid per d ay (see Table 3).
With regard to kin4ling, there were n o sigdi(ic ant dirr~renees in the Dumber of
stimula tioD! requir ed to evoke thr ee St?-ge-S se izures,~ = 45.1 , Xwo = 43.1 ,
and~ =45 ...4; E(2",30}= O:14~ p > 0 .05. Henc e, APM"animab did not req~ire
fewer e tt muleucne to produ ce seizur es (s ee Table 4).
,.
Figure 6 shows the cb ange in "ADT over daya. Ie.een be ~een th at grou p s 0 and
,,800~re initially tbe same at th e star t ofthe experime nt with group 200 being
slightly , but not significa ntly. above. It sh owsth at all gro uP9decreased ov er days
a~d th~t ·grOUP ~OO decr eased if!~AD.!.••mor~ thai! the ot.heryrou,p~. It ca~ alsobe
seen that there was a. c rossov er betwe en day 7 anlj. CST;- but tb,is was Dot
significa nt. Ad et ailed look ilt th 'e analzs is follows. ' .
~,' '. 'Anov erall Anal ysis or Variance was performed to dete rmine wh eiher ,tbe re were
\ any diff erences in ADT b~tween grou~~ over days and to determi ne wbe'tlie r there '
\ was an interaction b;~ween th e groups over 'd ays. ,Ir the~e w'b a ~eneral APM
. erred it would be reveal ed in the in tcr~tioD . Th ere were no significant 'd ifferences
between t~ e gr oupe, [(2,30) = 0.l G13, p ';; 0.0 5, nor -wes the r e an interaction
, . ~ween ~ups over da ys, [(6 ,90) = 1.14 , p > 0 .05. Hence, APM did n~t cause a.
. ' . ~d~rtcrcJic~ in brain excitability, There.·.w as,\howeverI a. significa nt difCerence in
. ' ,' '/ ADT o ve r aft da ys, [ (-3,GO) = il7.~I , P s: 0.001 (see TaMe 5), The ADT '
V . between Day o, Day I , 'nay ? a nd GST was:nol- the sa me ror· any or th e ,groups
(see Table 6 for the mea ns), AN ewman-Ku els test compa ring each day wit h every
other "sho wed ~h at the ADT~de~lined sign ificantl y' lor eac h day o f testing (n: y 0 '
> Day I >Day 7 > GST J.
Flgu .r;e 81
,
The ch8D~c in ADT ove r days for the th ree groups.
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Table 3: Two-Way Analysis or ve rtence to compare liquid consumption
pe' day or animals over the seven days or experimental
manipulation.
Soure e •• ss , lIS
. ..
.; _.~
','. " ., ~
G(GROl/PS) 964 .62 482 .31 1.03
S~SUBJECTS) 30 14082.6 0 469 . 75
D(DAYB) ; , ., 290. 95 48 .4 1 1.78
Ox!) ia 527 ;39. 43 .95 1. 62
D.S . 80 4998. •• 27 . 15
-------O--------------------T -----------------------------
'l"
',J
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Table 4: One-wey Analysis of Verien ce to compare the num ber of
stimulations required to kind le the euimels [i.e. to reach 3
stage-511eizures .
Source
G(GR0tn,'S)
df , ' 5
.9
lIS
19 .6 0 .14
ERROR 30 4083 138 :'0 :
--------~----------------------------------------_._--------
Table 5: Two-war Analysis ot Variance ror a' compa rison ot the ADT
tor the tbree groups, ror day 0, d ay I , day 1 and GST .
" )
--------------------------------------------_..----_...-----
SOURCE
. G(GRDUPS)
df SS
405.24
..
202.82 0 .10
S (SUBJECTS) 30 31767 . 50 1058 .92
D(DAYS)
GxC
D,S
3 -
90
8770 .27
1158 ~04
11990 . 47
2023 .42
109.87
77 .87
37 .114··
1.14
•• p ( 0 .01
~'.."
Table 8:
·2
\
Th e ave rage ADT ill jJA for the three grOUP! for Day 0, Day I,
Day 1 an d GST.
7
" .
CROUPS
---·- 1 ------------·----····---··------···----···---·- 1 -~--.
DAYS I Omg/tg M U 200q/tgAPil 800mg/kg APW lov. rall
---·· I ·----···_--_·_---_···_--_··_---_···_--_··---~-"I ----..
o I 46. 63" 63 . 45 46 .83 I 4d. 78
I I \
I 40.83 47. e g 40 .8 3 I 43 \48
1 1
I 38.2 6 39.23 37 . 08 1 37 . 73
1 I
CST I 30.63 26 . 00 28 .26 I 26 .82
overall 46.83 . 63 . 4«1 46 .8 3
I
I
"1
T~ ensure th at group differences were not present at the cutset, a: One-Way ';~
"Ana lysis ot Variance Wll!I completed for Day o. It,was found that',~here were .no
signi ficant dWeren~es in th e initial ADT for the groups OD -Da~before-aDY-.--· .
APM was introduced into th e _experimen~. Ther ercre , any difterence teen can~ot
be attr ibuted to differences with respeet to bas elineAD.I.l!!~ Tables 6 and 7).
'\ ~ ./ '.
. Th e short- term effecte of ArM ingestion were a.nalyzed by perfo~ing an , ~
Analysis of Var iance on ADT on Day O-aJt~ Day 1. There W8.9 a d~ya erre~t 'onIY
on ~T, [ (2 ,30)= 9 .97, p.~ O.oI(see Tables 6 and 8) .
Th e long-te rm effects of seven days of APM lngesn on were alsoexami~ed ,by',a
3(groups) x 2(days), analysis of variance. The two day s of importance here were
Day 7 and the day at ~hich ' GST: was J!1easured. There was a: sigtl i fica~t
difference in the th reshold over the tw~ days, r~1 .30) = -30.95, P S 0.01 (see
Ta bles 6 and 9). Bu t there wss no 6.rrect o f APM ingestion on groups x days
inte raction.
\
\
.:~.'
Table 71 One-Way Analysis of Variance to compare the three groups for
~T oo DayO. .
----------------~-----c--------------------- ---------~------
Source
G(GROUPS)
ERROR 30
s
468 .7 -40
13482 . 80
K'
234 . 37 0 . 62 ,
"
- ---- - -------- ---'-- --------- - - ----- - - ----------.._._----------
, .
<T ab le 8: T~W.y ADai"u 01Vari.D~e lor a eemperison of the AD'f
. for the three groups, lor day 0 aDd day 1.
.../
r
----:--.,-_:.:.._-------_:.._------------------------...._--..--------
G(GROUPS) 8~8 . 34 423 •.17 0 . 68
S (SUBJEcrS) 30 21830 .9 0 . 727 .89
D(DAYS) 4~4 .0~ . n4 .02 V.i7 ••
GzD 2 ? 33 1.1 7 0 .03
DxS ' 3D 1398.18 48 .64
-----------------------------------------.-------..----,
.. p .< 0 .01
.(
...;,
.l...;,~.".l•..•,..: '-
I 46
,\
Table 0: Two-Way Analysis of Varm{ce for a compar ison 'of th e ADT
ror the thr ee groups, for day 7 and CST .
SOURCE dl
"
I'"
!
o(GROUPS)
S(SUBJECTS) 30
D(DAYS)
e,,"
"'" 30
•• p ( 0 .01
\
31.17 16 .jiB 0 .03
13627 ,00 454 .26
)"gea'.64, 1063 .64 3~)' ge ••
\
183 .44 91.72 1.46
1002 .92 . ! 6;!,,~ _ . _- --- -
Dlseusslon
The hypothesis W 8.'I not confirmed: AP,M did not produ ce changes in AnT
durin g the ingestion procedure, nor did it decrease the rat e of kindling en ee APM
consumption was discontinued. It WR.!I expected that it APM altered brain
excita bility, even in the short-term, then ADT would .change between day 0 and
day l. T his was not the case here.
T he de termination of AD, for the subjects was observed from th e behavior~1
correlate, although the p'hysiological correlate '~as sometimes rather large when
compa red to the" litera tur e. T his discrepancy may _exist for several p08Sib~e
reasons; other literature studied ventral CA3 88 compar ed t.o dorsal CA3,
electrode impedance differences or filter setting dirrerences.
."; In this experiment two variables could have changed br:in tiss~citab;lit~ : '"
APM and kindling . Th~ee possible' outcomes ~ouid have occurred. TIie firs~~ and
expected , was that both of th ese variabl es would work together to prqdu ee a
synergistic effect, hence exd tability in APM animals would have been increased as
a result of these two variabl es, as determined by 'a groups x, day s int eract ion in
the analysis. The second possible ~utcome could have been an APM but no
kindling erred . 'Th is would hav e been determ ined by a groups effect in t~e
analysis, where groups wo~ have been significantly dirlerent. U this had
occurre d it would have opp~ed previous literat~re since kindling itseJr arlects
ADT . Hence, if this occurred APM would act as protection against altered brain
excitability. Therefore, if APM had an ef/ect it weeindependent 01 kindlbg. The
th ird possible outcome could have been a kindling but no APM eflect : ThU; would
have been demonstrated by a days elfect in tbe-ana lysls. The change in ADT, over
days would hav e been sign ifi~nt.
· many researche rs, for example Racin e (lg7 2A). Th e ADT for al! groups deerea.s~d
sign ificantly Ior each testing da y ADd th ere were no di~rereDces be tween wat er and
AP M groups. Hence th e magnitude of change wa; unalter ed an d there was no
interee tlon. Thu aI conclude th at under these condit ions APM does not change
brain. ex~ !tabili ty . Th is evideD~e is not in agree ment with t he findings of Maher
and W urtman (lgS7) and wha t w~ initi ally hypothesized in th is study. They
foun d that APMpromotes seizures in animals who were already .a t risk {that is,
animals treat ed with PT Z, Ilucrcth yl or electroshock]. These a nimals that were
given APM before the ' seizure ind ucing t reatmen t (PTZ, Ouol othy l or
eleetroshoek] had more convulsions than animals that were not given any APM
but j ust the seizure indu cing tre atment: The pres ent st udy shewed th at APM had
no dred on brain excit ability even with the ' sensitive kindling techniqu e. Th is
, study investig~ted her e may, be contrary to Mah er and Wurtm an (1087) because .
~hey g~~e'th"eit s:5ure i~dueing t~eatment ODe hour aft er APM ing~tion,,"Hence,
..th e plasma "Iud brain "levels or amino ecld e may ha ve been altered, thu s the results
revealing an . immediate br ain exch ability eUed :.Th e study performed h~re was .
more Int erested, in t he longer effects of APM and if any long term eUecla of r in
excita bility remain ed even after APM consumpt ion ceased.' Alth ough th e ~tt
term eUed s Were studi ed here (by measur ing ADT on days 0, 1 a nd 7) and it was
fou nd that APM did not. have an i~mediate erreet on brain excitabilit y when
studied' by the kindling model, APM does D~t cause the rat e of kindling to become
raster nor do~ it decrease the inten sity of stimulat ion needed to evoke an AD.
Th e raet th at there were no dlrt erenees among groups in t he amount of liquid
cesumed was in agreement with Sclafa ni and .Abra~ (~086J , Rats did bot ~efer
..,.., AP M ~ver wa ter ' for the a~.imals ree.eiv ing 2oomg/kg or SOOmgjkg of APM in
th eir dri nking-water Cor seven days. APM also did not ,have an eUect' on food
consu.mp'~n· or weight gai.n betw een the groups over th e experimental
manipulation. Ther efore, i\ did -not appear to upset their normal function s. Th e
group s' data' w ere all \ he same. 'rc'gardless of APM .ccnsump non . I( one of these
features had ~ cha nged along with "AP T or numb er ' of stimulations to kindl e
changed th en it ~ould have been dirrie~ lt to say w~at was s;eci fically eaus~ng th~ , '
effect, However, this was not the'ease ~ere, ,
T he absence of APM eUects on ADT and kindling ~aises two questions. First,
did APM ingestion increase plasma PIlE, ASP , TRP and TI'R ! Secoudly .vdid
elevated plasma· levels of these amino acids change brain concentratio ns of 5-HT, (,
TYR ,' r ifE.,. and TRP t 1-There may still have been no elted, as was shown by
. kindling and ADT measurements, 'bu t instead an ' ~Iteration.in plasma or brain or I
plasma and brain concentration of amino acids, The long-term effect, if th ereris
one, was not detect ed in brain...excitability In Area CA3 or tbe HipPOCamPUS,
bOW,r' it is'no t to say tha t all amino aci~' are normal}n the long-term,.or 'even
after three weeks. Th e n;xt logical step is to detern:!~ne plasma and :brain ~mino
acid levels &fter animals had-consumed APM for one week. This study will tell
one if the body compensate.. 'for constant alteration of the amino acid levels or
. ,, \ . ... ,. '
does there exist a altered amino acid plasma/ brain ra tio. Th e subsequent study
outlines such an experiment where -plasma end brain amino acid levels .'were
ana lyzed.
Plasma and Braln Amino Add AnaIY818':',~
The previous study has shown that th ere were no significant differeuees between
APM animals and ~ater animals in th e number 01 s timulatio~s required to kindle
Area qA~. nor was the.re a~y dilierence in the ADT between the groups. It is
possible t,hat there were ' no ellects because although APM ingestion had raised
brain tissue levels 01various amino acids this had not altered 'kindling or ADT. Or
it may be that the levels 01 APM ingestion had not ali~red amino acid levels in
breln tissue. Althou'gh the le! els used in the experjment were chosen on the ~asis
4i of other wor~, (Stegink, Koch, Blaskcvice, Filer, Baker and McDonnell, IgSl ) the
second possibility remains open.
" ,In order to distinguish between these two explanations for thf lack of errect a
supplementa ry experiment w~ performed Y> d~termin e it .there ~tually wrfs a
difference in pl~ma endbrein amino acid levels among the groups. If there was a
dlrterenee in plasma and not brain one can say tha t theebrain a~ts as a buffer lor
plasma .eminc acids [refer to BSB sect ion 01 the intToduction) hence not
permitting entrance. II th is is the case then intraventricular administratio~ ~f the
metabolites 01ArM may he a bett er route to determine the effects of APM on .../
. ain sensitivity. However, since we are interested in an analogue to the human
situation then this route or administration is ~~t eccepteble. . If there was a
difference in brain levels among the groups one could say tha~ APM Qoes 'aftect
b'rain amino 'acid levels with the possible concomitant -change hi. ratios of
neurotransmitters (Fernstrom and Wurtman, 1971). In that casS' the tests 01
kindling and ADT used in .the major experiment of this thesis, were not ~,
surticililnUy sensitive to detect an ellect or. the re was no eUeci.
Subjects. . . !
Forty-Iive Long-Evens rats were maintained on APM fdr seven days as outlined
in the previous study (1&animals on Omg/Kg of APM; 1&animals on 200mg/Kg
of APM; 15 animals on SOOmg/Kg of APM). The anim~],s weight was recorded
on day -I and sgain on day 7. Animals also had tree access to tood at- all rimes.
The av~age weight of the animal for each group at the start, of the .experi~ent
was 466.1g, 465.1g and 46&.8g for the OAPM group, the 200APM group and the
, . • , I
800AFM group, relfpectively. The .animals were given ~ree. access to a liq~~d and
the quantity drank w'as recorded daily. P lasma and tirains were obtained from
each animaL Ali"animals Weregiven a sUfficientamou~t of Sornnotol (85mgfK'iJ~
'0'aaesthesis. The skull bon" were opened an'd the ~"in, were removed h.ro, ' .
the 'plasma was ext racted. I,
P roced ure J
•
This was a 'blind experiment. The person who extricted blood and brain coded
th~amples and th en ga~'e the samples to another ' person .that ~ertormed the
' amino acid analysis procedur e. Hence, biases-were e!.~inated . .
P luma E][traetloD
B100i (~mi) was collected from the descending aorta in heparinized syringes.
The bleed was then transferred to centr ifuge tubes .and centrifuged for. l Omin at '
4000RPM S?' that the plasma could be obtained . The plasma (supernata nt)'Was
mixed with ~ equal amount of Lithiun1~ydroxide (pH 2.~) and then. injected into
the IIPLC amino aci~ analyzer (Beckman BulI~tin 121M~TB-q13) in the
Biochemistry Departmtmt.· The amin? acids of .interest have previously been
discussed In the intro duction and methbd of this thesis.
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Brain EdractloD . . ~
/
. Each anirnd'. br~n was removed and sliced at the point where the 8 'nal ecrd _
and cerebellum meet. The brain wu immediately placed between pr led (in .
~iqu id nit rogen) aluminium damp" lor immediate (reezing. Th e. brain w th en
pulverized. to • rLD~ powder. wiLb frequent 'additions of li~'trogen l
homogenized with 40% Peeehlorie eeid (4m1/gm or brain) and allowed to sta nd
lor lOolln. on cold iee 10 that the pro tein predpita~ed . Th e brain was then
. ceDtrif~ged 10 that a Iml aliquot of the 5uperutI.Dt eeuld be obtain~. which wu
~djusted to pH 2.2 b,. adt\ioo of ~ium hrd roxide. The HPLC analy~~ was
performed in t he Amino Add Analy! is racility or the Biocbenilitry Department at
Memorial University aI ' Newfoundland. One brain (rom each grou p wu
climin8~ed (ro~ the experiment lUI a result of breakage of the centrifuge tubes
durin-g'centrifugat ion.
Results
One animal', data bedto be removed from the 8tat is tic~1 ~nalysis. Th is animal
\ . '~ : .
. h~ levels that were at leest 3 8tandard deviat ions.above the avera~e .~ three of
the plasma 'amino acids measured. Hence, this out lier was removed from the
SOOAPM group.
A series of independent totals were performed between. th e three gr.oupt to
determine. if there were any si~ificant differences IUOOng the groups. Plasma
analysis revealed a 5i~ifi cant difference between ASP levels in plasma between
animals that drank 200mg/Kg of APM "and soOmg/Kg of APM 1!!W) = -1.81, P
< 0.05), as well as, a 8i~ifit~nt dirrerence between the Omg/Kg ol.APM animals '
anil Boomg/K go(APM animab for ASP ((min = ..2.13, P < '0.05). T here was
also a ~ign ificant difference in tyrosine concentration for th e Omg/Kg of APM
~n imals ~nd the BOOmg/Kg of AP~ an imals ((llll)) CII :2.66, p < 0.05). There
were no ot her differences found in th e other amino acids analyzed. T able 10·
sbows the means for the amino add s analyzed in the three groups.
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Another series of independent t-tests were also performed between the three
groups to determine if there was auf significant difference betweenthe &TOUpS.
Braiu 'amino acid analysis revealed DO significant difference.in any amino acid
st udied her e in brain between th e thr ee groups . T able 11 depicts tae means for
the amino acids analyzed in the three groups. •
There were no dirrerencee in liquid consumption among th e three group s ' over
t he seven da ya of APM/water ingestion . The average amo unt of liquid consum ed -
per day fot _the Omg/Kg APM animala "';&.8 Xa = 50.1300, th e 2oomg/Kg animals
Xzoo = 52.75ml, and the soo mg/Kg APM animals Xsoo = 61.1ml.
The re were no dirrerences in weight gain over the ser en dey ingesticn period for
,.the Omg/Kg APM animals, the 2oomg/Kg APM animals and the 800mgfKg APM
animals. Th e weight gains were 19.8g, 19.3gand IS.Sg, reSpectively.
/
time.
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DlecuaeloD
Overal l, th ere was Il difference ill plasma ASP bet ween 20G-800APM. ani mals
aDd o-sooAPM aDUnals. Th ere was also a difference! betweeo plasm~ tyrosi ne
. concent rat ion in the.~800APM uimals. Hcwerer, there were DO difl'erenees found
between &Dy am ino 'acid, tested ~ brain amoDS: the &TOups. T his differeuee in
plasma is Dot 'arrectiDC brain le..eU at the eoneentn t toD! 01 ArM used in th is
experiment . It is &bO of interest to note that \ we han Dot ' found the P HE
increment in plasma tha t has been rOUD~ in previous resea rch (Wurt man , 19838) .
T his was of importance because mostp~evious research extracted brain/ plu ma
immediately afte r APM consumptio n or every hair hour up to two hours afte r
APM ingest ion. T he ot ber stud ies t bat found amino ad d level differences also
used one teSt.load . Contr~ry to this, pleeme and bl~ were extr acted up to 6hr
artet APM/water cODs~~ption and these anima ls were maintained on the liquid
for seven daf';\Th erefore, insignificance in PHE may be due to a longer duration
for the liver to metabo lize the metaboli tes of APMor it may be that t here i!Ja
compensato ry mecha~ism that monito rs and eu.t reds high levels of circula~ing
PRE when PHE is in the plasma at high Mncentrations lor 8. prolooge4, period 01
. f .
J r > :Th e lad 01 elled in brai n levels ol .amino ti ds could. oot be attributed to:;.....- methodology probl ems. T he preparation of th "ds were done with sta ndard
procedure as that of high liquid chromatogra phy. Hence, tbe results found in th is
. experiment are probably not due to chance or experimental error .
""':- "'-
Recent research ~y Wurtman and Maher (l V.88) suggests that the concent ratio~
of 200mg/Kg 01' APM in rats . is not comparab le, to tbe 34mgJKg of APM i~
human s",Th ey suggest that due to the fa!lt rat e of metabo lism in rats as compared
to humans the cc neeneeetlon should be SOOmg/Kg 01 APM. II th is idea was
correct than th'e concent ration used in this experiment (800mg/K g AP~) should
bave been sufficient to produce an effect . However , this was not tbe ease.
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It is unlikely t~B.t humans would consume APM i.nhigher concentra tions than
used here. Hence, there appean not to be any detrlme ntal eered or ArM on th e
brain with regard to ADT changes or "possibly any other behavioral .or •
neurological construct. .
\
)
(
-' .
, \
Table 10: Th e average amino acid concent ra tion (om/mil in plasma for
the thr ee groups.
::; ,
. --./
-----------C-I--------------------------------------------
\Chemical I Glutamic . .
iAn.Ifui! I ASP Acid ' Glutuine TYR PHE my
Group\ I
c-----------I---------------------------------------------
I
O· Mil '162 .90 B8 .66 219 ,6B 23 .26 24 .27 14 .09
I .,
200 APU 1168 .41 94 .00 214 .33 25.63 26 .60 12 .49
I •
800 AJ!:),I 1239.29 91 .79 261.48 28.26 26 .69 13 .43
I
P ( ' 0 . 06 , • reterl to a signif icant dUflrlnee-bet.w.lJt---:'"""
the OAFId and 800APil groupa .
I reten to • 11gnlf1cut difference betwun
th, 200APJ.I and BOOAP'" groups.
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Table 11:
I
T he average amino acid concent ra tion (Dm/ ml) in br ain Ior the
three groups.
"\ ,
I
\
--~~~~~~~~-- :-------~~~~~~~-----~---~T-----~----------- .
\AulJzedl ASP Acid Glutamino TV! PIlE TRY
Group\ I
____ _, C1 . _
I'
APy. I 999 .21 2662 .69 1161.66 16 .31 14 .,89 2 .46
I ' . ~
200 APY 11032 .1 0 2611.70 1206 .71 16 .36 14 .71 2.81
I
800 ,\PM 11036 ,42 2777 .48 1200 .91 16 .61 16 .06 2 .46
I
OnraJl, APM did DOt arred the rate or kindling in AIel. clj of th~
Hip~ampw nor were the re any differences in brain eoneent reticns of the amino
eelds UDder study when an imah iD gel~ 0, 200, or 800 mg/Kg (of bod, weight)
. or APM. U the dbsage equiveleeee between humans Mnd rats is ecereet then (rom
these two studiel we ean say that 'APM would not bave any' Cen tr aJ Nervous"
System errect on ' norma)' subjects . Howev~r, there .may be certain subjecu that
are seDlit jve to cer taio amino eeid Iluetuet ions. Abo it may be that th e errect.s of
APM are a:dditiye and that over rime theamino acids may. become ~ven higher in
plasma and ~a!e more molecules available to compete for tr an srer acr oss the BDI)
a'Dd tben.arted ne~rological funct ioning.
. I
Th ere ere a number or othe r stud ies that can be done to determine the ertecte or
APM on br ain exc,i t~bi1ity ~ So~e ideas are given· in this pa;e;.· O'~e way w:
determine th e ertec'u of APM on th e development or s~i~res ~ould be ~ obta.i~ ., '1'
EEG's rro~ 8nimab tor Abueline period and .tben give the~ APM toigl'!Jt ror," ";'
th ree month period while obtaining daily EEG 's. Th e animals can the n bekindl~ "
. 1.0 det~rmi ne aoy di rtereeee in the rate of kindling between ~Up!l an d ~~ change .'
in EEG'S during ingestion. ADother study is to kindle animals first and lhen let .
the:.n eoaaume,APMin water IS W &.lI eereied out here. Thill would con;iDue 't~r a
re~nable' Ameuot o4I ime with 8iiim~ always being videotap~ to detect i t any ' . -.
spontaneous sl!b ure!J' were ' o«urring. 10 th ill exper iment yo u would be te!Jting
. wheth er epil; pt ica had mote seizures during APM~~sumpt ion or if there r were
any spontaneous eeisures. This st udy should ~Iso test ADT at various times to
determine it ~•.AD~ for APM epileptic~ w';' lowe; than the ADT ror Contr~
epileptics. 'An alternate way to exa mine the question would be to take the same
animals and only -d etermine their C ST to aee if it h~ significantly deereeeed tor
AJ:'M anima ls. Yet another would .be to repllcate the study completed in this.
. Ihes~ with ' 0 ee ",~Pt~" . eoetinue APM e?..umpu~,om D' r I .,til . ' imolo
,::'.'
.~ ~ \~'~~;" ' -
" exbibit,'tbree Stage-S .~iz u. res. ThD stu~y would..test the tran sient erreets or APM
on AnT .,.adrate or kiDdling.
T he.quesrioe or•. the errecls or APM ob. b~aiD excitability remains open. The
method used "jn this thesis refy on demou trat ing an average errecl. It does not
deal y.rit~ the..qeW!t ton 01 effects OR · susf~ptible· individuals. Given the present
finding" ~esearcla using method" appropriate to screening lor aensitive individuals
.. would be a user~l.ar~a to exam·ine. •
I
..-,
I '
"
. ''1.
..} '
•
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